Comparing cost-effectiveness analyses of denosumab versus zoledronic acid for the treatment of bone metastases.

Koo, Kaitlin

Comparing cost-effectiveness analyses of denosumab versus zoledronic acid for the treatment of bone metastases. [electronic resource] - Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer Jun 2013 - 1785-91 p. digital

Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Review

1433-7339

10.1007/s00520-013-1790-y doi


Antibodies, Monoclonal, Humanized--economics
Bone Neoplasms--drug therapy
Cost-Benefit Analysis
Denosumab
Diphosphonates--economics
Humans
Imidazoles--economics
Zoledronic Acid